Palvella Therapeutics Inc’s recent filing unveils that its Director JENKINS GEORGE M acquired Company’s shares for reported $50472.0 on Apr 09 ’25. In the deal valued at $20.27 per share,2,490 shares were bought. As a result of this transaction, JENKINS GEORGE M now holds 13,516 shares worth roughly $0.3 million.
Then, JENKINS GEORGE M bought 2,500 shares, generating $50,325 in total proceeds. Upon buying the shares at $20.13, the Director now owns 183,171 shares.
Before that, JENKINS GEORGE M bought 4,000 shares. Palvella Therapeutics Inc shares valued at $51,720 were divested by the Director at a price of $12.93 per share. As a result of the transaction, JENKINS GEORGE M now holds 180,671 shares, worth roughly $3.99 million.
Chardan Capital Markets initiated its Palvella Therapeutics Inc [PVLA] rating to a Buy in a research note published on April 09, 2025; the price target was $50. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in late March with a ‘”a Buy”‘ rating. Scotiabank began covering PVLA with “Sector outperform” recommendation on March 07, 2025. Canaccord Genuity started covering the stock on February 20, 2025. It rated PVLA as “a Buy”.
Price Performance Review of PVLA
On Friday, Palvella Therapeutics Inc [NASDAQ:PVLA] saw its stock jump 7.08% to $22.08. Over the last five days, the stock has gained 0.14%. Palvella Therapeutics Inc shares have risen nearly 153.50% since the year began. Nevertheless, the stocks have risen 84.00% over the past one year. While a 52-week high of $29.27 was reached on 03/13/25, a 52-week low of $6.20 was recorded on 01/02/25.
Levels Of Support And Resistance For PVLA Stock
The 24-hour chart illustrates a support level at 20.39, which if violated will result in even more drops to 18.70. On the upside, there is a resistance level at 23.73. A further resistance level may holdings at 25.38.
How much short interest is there in Palvella Therapeutics Inc?
A steep rise in short interest was recorded in Palvella Therapeutics Inc stocks on 2025-06-13, growing by 98235.0 shares to a total of 0.39 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.29 million shares. There was a rise of 25.37%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 05, 2025 when TD Cowen began covering the stock and recommended ‘”a Buy”‘ rating along with a $44 price target.
